Health & Medicine
-
Abuja Project Gives 10,000 Households Free LPG Cylinders to Cut Cooking Smoke Exposure
The smoke in her kitchen had a name. For years, that was just how cooking worked. Firewood. Charcoal. Kerosene. The fumes sat…
-
Existing drug could speed new treatment for rare liver cancer
ITHACA, N.Y., July 5 — Inside a rare and aggressive liver cancer that primarily strikes children and young adults, scientists have mapped…
-
Researchers Identify Why Immunotherapy Fails in Rare Liver Cancer Fibrolamellar Carcinoma
ITHACA, N.Y. — A drug already sitting on pharmacy shelves may offer a new way to attack a rare liver cancer that…
-
Tel Aviv researchers uncover cancer growth mechanism
TEL AVIV, July 4 — Researchers at Tel Aviv University have documented a mechanism by which cancerous tumors hijack a routine immune-system…
-
Hidden Dependency in Fast-Growing Tumors Unlocks New Cancer Treatment
LOS ANGELES, July 4 — For families facing some of the most aggressive cancers, a discovery out of UCLA this week offers…
-
Air traffic control engineers cycle 1,000 miles after colleague’s prostate cancer death
Prostate cancer kills one man every 45 minutes in the UK. That statistic hung over a group of air traffic control engineers…
-
Goldup’s ignored neck mark turned out to be deadly melanoma
FARNHAM, July 3 — A mother who dismissed a mark on her neck as a birthmark for years has spoken about her…
-
Tata Memorial Papaya Leaf Extract Trial Faces Journal Concern Over Platelet Results
MUMBAI, July 3 — A new Phase III randomised clinical trial from Tata Memorial Centre’s GI medical oncology department has validated the…
-
Rare thyroid cancer’s biology and inherited risks uncovered
SINGAPORE, July 3 — For families across Asia facing a diagnosis of medullary thyroid cancer, a rare form of the disease, the…
-
Global Cervical Cancer Treatment Market to Hit $14.43B by 2034
NEW YORK, July 3 — Behind every number in a market report is a person. A mother, a sister, a friend. That’s…
-
Oregon Emergency Doctors Use New State Law to Beat a National Staffing Company
MANILA — The emergency physicians who refused to be swallowed by a larger hospital system did not just win a legal fight.…
-
Modified Vitamin B12 Stays Active in Glioblastoma Tumors for 24 Hours in Animal Study
For decades, the blood-brain barrier has been the rule that keeps glioblastoma patients alive just 15 months. That rule may be changing.…
-
Researchers Use Vitamin B12 to Deliver Glioblastoma Drug Past Blood-Brain Barrier
History is littered with promising cancer treatments that worked beautifully in mice and then fell apart in people. That sobering fact hangs…
-
Modified Vitamin B12 Crosses Blood-Brain Barrier and Targets Glioblastoma in Animal Study
Glioblastoma kills. It kills fast. Most patients get fifteen months, if they’re lucky. Surgery, radiation, chemotherapy — the standard toolkit — rarely…
-
New Infrastructure Planning Guidance Mandates Health Impact Assessments
The government’s new national infrastructure planning guidance runs through a set of numbers that define how major projects in England will get…
-
Scientists Used Vitamin B12 to Sneak a Cancer-Killer into the
NEW YORK, July 3 — In a clever bit of biological smuggling, scientists have used vitamin B12 to sneak a cancer-killing agent…
-
Fatty Liver Linked to More Aggressive Spread of Bowel Cancer to the Liver, Study Finds
LONDON, July 3 — A fatty liver may be more than a metabolic warning sign. New research published in the journal Nature…
-
Oncologist warns breast cancer signs go beyond a lump
LONDON, July 3 — Actress and presenter Lisa Faulkner has revealed she underwent surgery for early-stage breast cancer, a diagnosis she said…
-
Actress Lisa Faulkner reveals early-stage breast cancer after routine mammogram
One woman in the UK receives a breast cancer diagnosis every ten minutes. That statistic, from research charity Breast Cancer Now, is…
-
Vitamin B12 compound shows promise against deadly brain cancer
BOSTON — A modified form of vitamin B12, designed to deliver nitric oxide directly to tumors, has shown promise in early animal…
-
Modified vitamin B12 compound reaches brain tumors in animal study and stays active
A modified vitamin B12 compound that sneaks past the brain’s defenses has cleared animal testing for glioblastoma. The next steps are concrete,…
-
Modified vitamin B12 compound reaches glioblastoma tumors and boosts chemotherapy in early study
For the roughly 12,000 Americans diagnosed each year with glioblastoma, the math is brutal. Median survival: under 15 months. Standard treatment —…
-
Modified B12 compound with nitric oxide targets glioblastoma in animal tests
Glioblastoma patients have a grim clock. Median survival: under 15 months. Even with surgery, radiation, and chemotherapy, the tumor almost always returns.…
-
Father’s Hope Shattered as Rare Brain Cancer Returns
SOUTH SHIELDS, July 2 — A first-time father has been told he has up to 12 months to live after a routine…
Most read
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Dynasty Trusts Preserve Wealth for a Century Using GST Exemptions
-
Experimental Drug Combo Doubles One-Year Survival Rates in Pancreatic Cancer Trial
-
Factor XIa Inhibitor Asundexian Cuts Recurrent Stroke Risk Without Raising Major Bleeding
-
UCSF Scientists Eliminate Deadly Brain Tumors in Mice with B-SYNC Therapy
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Why Achieve Says Most Americans Feel Their Financial Stability is Slipping Away
-
Locking In High Yields: How Current CD Rates Offer Safe Returns Amid Shifting Economic Outlooks
-
Medicare Denies $949 Multi-Cancer Blood Test, Leaving Seniors With Full Bill Until 2029
-
India’s NPPA slashes 137 cancer drug prices by up to 96%, saving ₹3,500 crore annually
-
Inside AbbVie’s High-Stakes Neuro Portfolio and Pipeline Strategy
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992